Skip to content
DataLookout
Menu

NCT07472959

Effect of Intraoperative Morphine on Postoperative Pain After CABG

StatusCompleted
PhasePhase 4
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 14 words Show 6 more changesShow less
    • Trial completed
    • Final enrollment: 80 participants (planned 60)
    • Primary completion date changed from estimate of May 1, 2026 to Jun 26, 2026
    • Study completion date changed from estimate of May 31, 2026 to Sep 11, 2026
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

VAS Level
Timeframe: 1st, 2nd, 4th, 8th, and 24th hours after extubation.

Secondary (1)

PONV

Arms and interventions

Group C (control group)No intervention

Patients in this group received a standard fentanyl infusion during the entire CABG procedure until they were transferred out of the operating room."

Group M (group morphine)Experimental

Patients in this group received 5 mg of morphine prior to the initiation of the surgical procedure and an additional 5 mg at the time of separation from cardiopulmonary bypass.

Drugs: In this study, morphine administration, which is routinely and frequently used in our operating room for patients undergoing CABG, was applied as an additional intervention

Sites

1 site in 1 country

  • Istanbul University -Cerrahpasa Institute of CardiologyIstanbul, Outside of the US, Turkey (Türkiye)